• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.ASO作者反思：对于降低肝门部胆管癌手术-门静脉栓塞的不良结局至关重要。
Ann Surg Oncol. 2020 Jul;27(7):2319-2320. doi: 10.1245/s10434-020-08333-9. Epub 2020 Mar 9.
2
Portal Vein Embolization for Perihilar Cholangiocarcinoma: A Story Worth Repeating.
Ann Surg Oncol. 2020 Jul;27(7):2120-2121. doi: 10.1245/s10434-020-08280-5. Epub 2020 Feb 28.
3
ASO Author Reflections: Laparoscopic Surgery of Perihilar Cholangiocarcinoma Between Oncologic Adequacy and Technical Challenges.ASO作者反思：肝门部胆管癌的腹腔镜手术——肿瘤学充分性与技术挑战之间
Ann Surg Oncol. 2020 Dec;27(13):5193-5194. doi: 10.1245/s10434-020-08660-x. Epub 2020 May 26.
4
Hepatopancreatoduodenectomy with simultaneous resection of the portal vein and hepatic artery: Ultimate superextended surgery for advanced perihilar cholangiocarcinoma.门静脉和肝动脉同时切除的肝胰十二指肠切除术：晚期肝门部胆管癌的终极超扩大手术
J Hepatobiliary Pancreat Sci. 2022 Jun;29(6):597-599. doi: 10.1002/jhbp.1102. Epub 2021 Dec 30.
5
ASO Author Reflections: Left Trisectionectomy for Bismuth-Corlette Type IV Perihilar Cholangiocarcinoma with Left-Sided Predominance.ASO作者反思：针对以左侧为主的Bismuth-Corlette IV型肝门部胆管癌行左半肝切除术。
Ann Surg Oncol. 2020 Jul;27(7):2387-2388. doi: 10.1245/s10434-020-08445-2. Epub 2020 Apr 22.
6
ASO Author Reflections: Chasing a Microscopic Cancer-Free Margin During Resection for Perihilar Cholangiocarcinoma: Can Additional Resection Improve the Long-Term Outcomes?ASO作者反思：在肝门部胆管癌切除术中追求显微镜下无癌切缘：额外切除能否改善长期预后？
Ann Surg Oncol. 2023 Jun;30(6):3360-3361. doi: 10.1245/s10434-023-13197-w. Epub 2023 Feb 7.
7
ASO Author Reflections: Robotic Klatskin Type 3A Resection with Biliary Reconstruction: Can this Emerging Minimally Invasive Technique Become an Alternative Approach to Open Surgery for Perihilar Cholangiocarcinoma?ASO作者反思：机器人辅助肝门部3A型胆管癌切除术及胆道重建：这种新兴的微创技术能否成为肝门部胆管癌开放手术的替代方法？
Ann Surg Oncol. 2023 Dec;30(13):8012-8013. doi: 10.1245/s10434-023-14298-2. Epub 2023 Sep 19.
8
Narrowing of the remnant portal vein diameter and decreased portal vein angle are risk factors for portal vein thrombosis after perihilar cholangiocarcinoma surgery.残余门静脉直径变窄和门静脉夹角减小是肝门周围胆管癌手术后门静脉血栓形成的危险因素。
Langenbecks Arch Surg. 2021 Aug;406(5):1511-1519. doi: 10.1007/s00423-020-02044-1. Epub 2021 Jan 6.
9
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure for cholangiocarcinoma.联合肝脏离断和门静脉结扎的分阶段肝切除术（ALPPS）治疗胆管癌。
Int J Surg. 2020 Oct;82S:97-102. doi: 10.1016/j.ijsu.2020.06.045. Epub 2020 Jul 7.
10
ASO Author Reflections: Total Laparoscopic Resection of Perihilar Cholangiocarcinoma: What is Ahead?ASO作者反思：肝门部胆管癌的全腹腔镜切除术：未来何去何从？
Ann Surg Oncol. 2023 Aug;30(8):4874-4875. doi: 10.1245/s10434-023-13625-x. Epub 2023 May 16.

本文引用的文献

1
Portal Vein Embolization is Associated with Reduced Liver Failure and Mortality in High-Risk Resections for Perihilar Cholangiocarcinoma.门静脉栓塞术与高位胆管癌高危切除术后肝衰竭和死亡率降低相关。
Ann Surg Oncol. 2020 Jul;27(7):2311-2318. doi: 10.1245/s10434-020-08258-3. Epub 2020 Feb 26.
2
Morbidity and mortality after major liver resection in patients with perihilar cholangiocarcinoma: A systematic review and meta-analysis.肝门部胆管癌患者行大肝切除术后的发病率和死亡率：系统评价和荟萃分析。
Surgery. 2019 May;165(5):918-928. doi: 10.1016/j.surg.2019.01.010. Epub 2019 Mar 11.
3
A comparison of treatment and outcomes of perihilar cholangiocarcinoma between Eastern and Western centers.东西方中心肝门部胆管癌治疗和结局的比较。
HPB (Oxford). 2019 Mar;21(3):345-351. doi: 10.1016/j.hpb.2018.07.014. Epub 2018 Aug 4.
4
Postoperative Liver Failure Risk Score: Identifying Patients with Resectable Perihilar Cholangiocarcinoma Who Can Benefit from Portal Vein Embolization.术后肝功能衰竭风险评分：识别可从门静脉栓塞中获益的可切除肝门部胆管癌患者。
J Am Coll Surg. 2017 Sep;225(3):387-394. doi: 10.1016/j.jamcollsurg.2017.06.007. Epub 2017 Jul 4.
5
Tc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma.锝-美罗芬宁肝胆闪烁显像可预测肝门部胆管癌肝大部切除术后的肝衰竭。
HPB (Oxford). 2017 Oct;19(10):850-858. doi: 10.1016/j.hpb.2017.05.007. Epub 2017 Jul 4.

ASO Author Reflections: Essential to Reduce Adverse Outcomes in Perihilar Cholangiocarcinoma Surgery-Portal Vein Embolization.

作者信息

Olthof Pim B, van Gulik Thomas M

机构信息

Department of Surgery, Amsterdam UMC (Location AMC), University of Amsterdam, Amsterdam, The Netherlands.

Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.

出版信息

Ann Surg Oncol. 2020 Jul;27(7):2319-2320. doi: 10.1245/s10434-020-08333-9. Epub 2020 Mar 9.

DOI:10.1245/s10434-020-08333-9
PMID:32152772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7311505/
Abstract
摘要